Heska Corporation (HSKA) EPS Estimated At $0.40 on May, 4

May 3, 2018 - By Joshua Cleveland

During 2017 Q4 the big money sentiment decreased to 0.77. That’s change of 0.49, from 2017Q3’s 1.26. 20 investors sold all, 51 reduced holdings as Heska Corporation ratio dived. 34 grew holdings while 21 funds took holdings. Funds hold 5.99 million shares thus 8.21% more from 2017Q3’s 5.53 million shares.
Arizona State Retirement reported 10,958 shs stake. Manufacturers Life Com The has invested 0% of its capital in Heska Corporation (NASDAQ:HSKA). Clarivest Asset Management Limited Liability Company, a California-based fund reported 7,500 shs. Blackhill owns 700 shs for 0.01% of their capital. Blackrock holds 880,414 shs. Parametric Ltd Com holds 0% or 6,692 shs in its capital. Raymond James And Associate invested in 0% or 3,681 shs. Daruma Capital Mgmt Limited Com reported 0.08% stake. Ftb Advisors invested 0% of its capital in Heska Corporation (NASDAQ:HSKA). Nj State Employees Deferred Compensation Plan reported 0.14% of its capital in Heska Corporation (NASDAQ:HSKA). New York State Common Retirement Fund owns 7,200 shs. Fred Alger Mgmt owns 139,120 shs. Neuberger Berman Lc invested 0.06% in Heska Corporation (NASDAQ:HSKA). Cornerstone Mngmt Holdings Ltd Llc stated it has 2,529 shs. Grace & White New York reported 81,210 shs.

Heska Corporation (NASDAQ:HSKA) is awaited to reveal earnings on May, 4 before the open., RTT reports. Analysts predict 34.43 % diference or $0.40 from the $0.61 EPS from 2017. If earnings per share of $0.40 is reported the profit of HSKA could be $2.97 million giving it 53.27 P/E. Last quarter $0.63 earnings per share was reported. Analysts forecasts -36.51 % negative EPS growth this quarter. Ticker’s shares touched $85.23 during the last trading session after 3.10% change.Currently Heska Corporation is downtrending after 19.59% change in last May 3, 2017. HSKA has 93,019 shares volume. HSKA underperformed by 31.14% the S&P500.

Heska Corporation (NASDAQ:HSKA) Ratings Coverage

Total analysts of 2 have positions in Heska Corp (NASDAQ:HSKA) as follows: 1 rated it a “Buy”, 0 with “Sell” and 1 with “Hold”. The positive are 50%. Since December 4, 2017 according to StockzIntelligence Inc Heska Corp has 2 analyst reports. On Thursday, March 1 the stock of Heska Corporation (NASDAQ:HSKA) has “Neutral” rating given by B. Riley & Co.

Heska Corporation develops, manufactures, and markets advanced veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Europe, and internationally.The company has $633.05 million market cap. It operates through two divisions, Core Companion Animal Health; and Other Vaccines, Pharmaceuticals and Products.The P/E ratio is 65.56. The Core Companion Animal Health segment offers Element DC and DRI-CHEM 7000 veterinary chemistry analyzers for blood chemistry and electrolyte analysis; HT5 and HEMATRUE veterinary hematology analyzers to measure white and red blood cell count, platelet count, and hemoglobin levels in animals; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and IV pumps.

Heska Corporation (NASDAQ:HSKA) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.